Search - tctmd.com

Presenter: Jai-Wun Park, Jai-Wun Park, Horst Sievert, Wolfgang Schillinger, Lars Lickfett, Jose Ramon Lopez-Minguez, Heyder Omran, Mariano Valdes, Benno Hennen, Kevin Walsh, Oliver Ormerod, Peter Neuzil, Rainer Schraeder, Eulogio Garcia, David Hildick-Smith, Roman Lezaun

January 31, 2013

Presentation TCT 2013

Optimizing plugs size for transcatheter paravalvular leak closure with Amplatzer Vascular Plug III devices.

Presenter: Grzegorz Smolka, Piotr Pysz, Ewa Peszek-Przybyla, Przemyslaw Zurek, Zbigniew Gasior, Andrzej Ochala

January 31, 2013

Presentation TCT 2013

Long-term results of a comparison of three patent foramen ovale closure devices in a randomized trial (Amplatzer versus CardioSEAL-STARflex versus Helex occluder)

Presenter: Marius Hornung, Jennifer Franke, Stefan Bertog, Margaret Taaffe, Laura Vaskelyte, Undine Pittl, Ilona Hofmann, Horst Sievert

January 31, 2013

Presentation TCT 2013

Early Safety of the Amplatzer Cardiac Plug™ for Left Atrial Appendage Occlusion

Presenter: David Meerkin, Adi Butnaru, Dmitry Dratva, Olivier Bertrand, Dan Tzivoni

January 31, 2013

News Industry News

St. Jude Medical Receives CE Mark of Next-Generation Cardiac Device for Stroke Prevention

January 17, 2013

News Daily News

Percutaneous Device-Based Closure Successful in Children with Ventricular Septal Defects

L.A. McKeown

November 14, 2012

News Daily News

El Cierre Percutáneo con ayuda de un Dispositivo tiene Éxito en Niños con Defectos Septales Ventriculares

L.A. McKeown

November 14, 2012

Presentation

Transcatheter Retrograde Closure of Perimembranous VSD in Children with the Amplatzer Duct Occluder II Device

Presenter: Nageswara Rao Koneti

November 12, 2012

News Industry News

Gore Reacts to RESPECT Trial Results

October 26, 2012

News Conference News TCT 2012

Two Trials Examine Device-Based PFO Closure

October 25, 2012

News Industry News

St. Jude Medical RESPECT Trial for PFO Closure Provides Clinical Evidence of Risk Reduction in Prevention of Recurrent Cryptogenic Stroke

October 25, 2012

News Conference News TCT 2012

Novel Devices Provide Options for LAA Therapy

October 25, 2012

News Industry News

Clinical Trial Suggests PFO Closure with Investigational Device is Safe and May Improve Clinical Outcomes Compared to Medical Management in the Prevention of Cryptogenic Stroke

October 25, 2012

News Industry News

Clinical Trial Shows that PFO Closure With Investigational Device Does Not Decrease Ischemic and Bleeding Events Compared to Medical Therapy

October 25, 2012

Presentation TCT 2012

Next-Generation LAA Occlusion Devices: AMPLATZER (St. Jude Medical) and WAVECREST (Coherex Medical)

Presenter: Horst Sievert

October 24, 2012

Presentation TCT 2012

TCT-86. Results of the Amplatzer Cardiac Plug European Multicenter Prospective Observational Study

Presenter: Jai-Wun Park

October 23, 2012

News Daily News

Headache or No Headache, PFO-Related Auras Have Same Cause

June 19, 2012

Advertisement

NEJM Publishes Two More Trials Weakening the Case for PFO Closure

El NEJM Publica 2 Ensayos Más que Debilitan el Caso del Cierre del FOP

Data from St. Jude Medical RESPECT Trial for PFO Closure Highlighted at International Stroke Conference 2013

Results of the Amplatzer Cardiac Plug European Multicenter Prospective Observational Study

Optimizing plugs size for transcatheter paravalvular leak closure with Amplatzer Vascular Plug III devices.

Long-term results of a comparison of three patent foramen ovale closure devices in a randomized trial (Amplatzer versus CardioSEAL-STARflex versus Helex occluder)

Early Safety of the Amplatzer Cardiac Plug™ for Left Atrial Appendage Occlusion

St. Jude Medical Receives CE Mark of Next-Generation Cardiac Device for Stroke Prevention

Percutaneous Device-Based Closure Successful in Children with Ventricular Septal Defects

El Cierre Percutáneo con ayuda de un Dispositivo tiene Éxito en Niños con Defectos Septales Ventriculares

Transcatheter Retrograde Closure of Perimembranous VSD in Children with the Amplatzer Duct Occluder II Device

Gore Reacts to RESPECT Trial Results

Two Trials Examine Device-Based PFO Closure

St. Jude Medical RESPECT Trial for PFO Closure Provides Clinical Evidence of Risk Reduction in Prevention of Recurrent Cryptogenic Stroke

Novel Devices Provide Options for LAA Therapy

Clinical Trial Suggests PFO Closure with Investigational Device is Safe and May Improve Clinical Outcomes Compared to Medical Management in the Prevention of Cryptogenic Stroke

Clinical Trial Shows that PFO Closure With Investigational Device Does Not Decrease Ischemic and Bleeding Events Compared to Medical Therapy

Next-Generation LAA Occlusion Devices: AMPLATZER (St. Jude Medical) and WAVECREST (Coherex Medical)

TCT-86. Results of the Amplatzer Cardiac Plug European Multicenter Prospective Observational Study

Headache or No Headache, PFO-Related Auras Have Same Cause

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content